About Publications
Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
-
Accounting for Social Risk Factors in Medicare Payment: Data ...
Released: October 11, 2016
The Department of Health and Human Services, acting through the Office of the Assistant Secretary for Planning and Evaluation, asked the National Academies of Sciences, Engineering, and Medicine to convene an ad hoc committee to identify social risk factors that affect the health outcomes of Medicare beneficiaries and methods to account for these factors in Medicare payment programs. The committee's work will be conducted in phases and will produce five brief consensus reports.
-
Exploring the Role of Accreditation in Enhancing Quality and ...
Released: October 05, 2016
The purpose of accreditation is to build a competent health workforce by ensuring the quality of training taking place within those institutions that have met certain criteria. Given the rapid changes in society, health, and health care, members of the Global Forum on Innovation in Health Professional Education elected to take on the topic of accreditation and to explore the effect of societal shifts on new and evolving health professional learning opportunities to best ensure quality education is offered by institutions regardless of the program or delivery platform.
-
Exploring Data and Metrics of Value at the Intersection of ...
Released: September 26, 2016
Two divisions of the National Academies of Sciences, Engineering, and Medicine, the Health and Medicine Division (HMD) and the Transportation Research Board (TRB), held a joint workshop, Exploring Data and Metrics of Value at the Intersection of Health Care and Transportation on June 6–7, 2016, to examine partnerships, data, and measurement at the intersection of the health care and transportation sectors.
-
Making Eye Health a Population Health Imperative: Vision for ...
Released: September 15, 2016
Despite the importance of eyesight, millions of people grapple with undiagnosed or untreated vision impairments—ranging from mild conditions to total blindness—and eye and vision health remain relatively absent from national health priority lists, says a new report from the National Academies of Sciences, Engineering, and Medicine.
-
Families Caring for an Aging America : Health and Medicine ...
Released: September 13, 2016
At least 17.7 million individuals in the United States are providing care and support to an older parent, spouse, friend, or neighbor who needs help because of a limitation in their physical, mental, or cognitive functioning.
-
-
-
Strategies for Ensuring Diversity, Inclusion, and Meaningful ...
Released: August 26, 2016
To examine the barriers to participation in clinical trials and ways of overcoming those barriers, the Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities held a workshop, on April 9, 2015, titled “Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials.”
-
Engaging the Private Sector and Developing Partnerships to ...
Released: August 25, 2016
Recognizing the importance of the Sustainable Development Goals (SDGs) in setting global development priorities for the next 15 years, on June 23–24, 2016, the Forum on Public–Private Partnerships for Global Health and Safety (PPP Forum) held a public workshop titled “Engaging the Private Sector and Developing Partnerships to Advance Health and the Sustainable Development Goals”.
-
Neuroscience Trials of the Future: Proceedings of a Workshop ...
Released: August 19, 2016
On March 3–4, 2016, the National Academies of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous System Disorders held a workshop in Washington, DC, bringing together key stakeholders to discuss opportunities for improving the integrity, efficiency, and validity of clinical trials for nervous system disorders.